• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴雷特食管和食管腺癌:新的综合治疗时机。

Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.

机构信息

Divisions of Public Health Sciences and Human Biology, Fred Hutchinson Cancer Research Center, University of Washington, 98109 Seattle, USA.

出版信息

Nat Rev Cancer. 2010 Feb;10(2):87-101. doi: 10.1038/nrc2773.

DOI:10.1038/nrc2773
PMID:20094044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2879265/
Abstract

The public health importance of Barrett's oesophagus lies in its association with oesophageal adenocarcinoma. The incidence of oesophageal adenocarcinoma has risen at an alarming rate over the past four decades in many regions of the Western world, and there are indications that the incidence of this disease is on the rise in Asian populations in which it has been rare. Much has been learned of host and environmental risk factors that affect the incidence of oesophageal adenocarcinoma, and data indicate that patients with Barrett's oesophagus rarely develop oesophageal adenocarcinoma. Given that 95% of oesophageal adenocarcinomas arise in individuals without a prior diagnosis of Barrett's oesophagus, what strategies can be used to reduce late diagnosis of oesophageal adenocarcinoma?

摘要

巴雷特食管的公共卫生重要性在于其与食管腺癌的关联。在过去的四十年中,在西方世界的许多地区,食管腺癌的发病率以惊人的速度上升,有迹象表明,在亚洲人群中,这种疾病的发病率在罕见的情况下也在上升。人们已经了解了许多宿主和环境危险因素,这些因素会影响食管腺癌的发病率,并且数据表明,患有巴雷特食管的患者很少发展为食管腺癌。鉴于 95%的食管腺癌发生在没有巴雷特食管先前诊断的个体中,那么有哪些策略可以用于减少食管腺癌的晚期诊断?

相似文献

1
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.巴雷特食管和食管腺癌:新的综合治疗时机。
Nat Rev Cancer. 2010 Feb;10(2):87-101. doi: 10.1038/nrc2773.
2
Barrett's oesophagus: frequency and prediction of dysplasia and cancer.巴雷特食管:发育异常和癌症的发生率及预测
Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):125-38. doi: 10.1016/j.bpg.2015.01.001. Epub 2015 Jan 20.
3
Chemoprevention in Barrett's oesophagus.巴雷特食管的化学预防
Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):151-65. doi: 10.1016/j.bpg.2014.12.003. Epub 2014 Dec 29.
4
Malignant Barrett's oesophagus.恶性巴雷特食管
Eur J Cancer Prev. 1993 Jan;2(1):47-52. doi: 10.1097/00008469-199301000-00008.
5
Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota.明尼苏达州奥尔姆斯特德县巴雷特食管的流行病学及转归的长期趋势
Gut. 2001 Mar;48(3):304-9. doi: 10.1136/gut.48.3.304.
6
Barrett's oesophagus: Current controversies.巴雷特食管:当前的争议。
World J Gastroenterol. 2017 Jul 28;23(28):5051-5067. doi: 10.3748/wjg.v23.i28.5051.
7
[Revision needed of follow-up policy for Barrett's esophagus].[巴雷特食管随访策略需修订]
Ned Tijdschr Geneeskd. 2002 Jan 26;146(4):150-4.
8
Barrett's oesophagus: epidemiology, cancer risk and implications for management.巴雷特食管:流行病学、癌症风险及管理意义。
Gut. 2014 Jan;63(1):191-202. doi: 10.1136/gutjnl-2013-305490. Epub 2013 Oct 3.
9
Prognostic value of p53 in Barrett's oesophagus.p53在巴雷特食管中的预后价值。
Eur J Gastroenterol Hepatol. 1995 Jan;7(1):81-4.
10
Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus.饮食因素与食管腺癌和 Barrett 食管的风险。
Nutr Res Rev. 2010 Dec;23(2):230-46. doi: 10.1017/S0954422410000132. Epub 2010 Jul 13.

引用本文的文献

1
Infectious Agents and Esophageal Cancer: A Comprehensive Review.感染因子与食管癌:全面综述
Cancers (Basel). 2025 Apr 7;17(7):1248. doi: 10.3390/cancers17071248.
2
Biologically targeted discovery-replication scan identifies G×G interaction in relation to risk of Barrett's esophagus and esophageal adenocarcinoma.生物靶向性发现-重复扫描识别出与巴雷特食管和食管腺癌风险相关的基因×基因相互作用。
HGG Adv. 2025 Apr 10;6(2):100399. doi: 10.1016/j.xhgg.2025.100399. Epub 2025 Jan 3.
3
Red dichromatic imaging and linked color imaging as reliable image-enhanced endoscopic procedures for detecting the distal end of the palisade vessels in the columnar metaplastic mucosa of the gastroesophageal junction zone.

本文引用的文献

1
Attitudes, norms and controls influencing lifestyle risk factor management in general practice.影响全科医疗中生活方式风险因素管理的态度、规范和控制措施。
BMC Fam Pract. 2009 Aug 26;10:59. doi: 10.1186/1471-2296-10-59.
2
When mutants gain new powers: news from the mutant p53 field.当突变体获得新能力时:来自突变型p53领域的消息。
Nat Rev Cancer. 2009 Oct;9(10):701-13. doi: 10.1038/nrc2693. Epub 2009 Aug 20.
3
Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic.巴雷特食管的非内镜筛查生物标志物:从微阵列分析到临床应用
红色双对比成像和链接颜色成像作为可靠的内镜增强成像技术,可用于检测胃食管连接区柱状化生黏膜中栅栏血管的远端。
J Gastroenterol. 2024 Aug;59(8):647-657. doi: 10.1007/s00535-024-02118-7. Epub 2024 Jun 5.
4
Multifunctional Ablative Gastrointestinal Imaging Capsule (MAGIC) for Esophagus Surveillance and Interventions.用于食管监测和干预的多功能消融性胃肠道成像胶囊(MAGIC)
BME Front. 2024 Apr 3;5:0041. doi: 10.34133/bmef.0041. eCollection 2024.
5
The Role of Long Noncoding RNAs (lncRNAs) in Esophageal Cancer Therapy Resistance and Metastasis.长链非编码RNA(lncRNAs)在食管癌治疗耐药性和转移中的作用
Biomedicines. 2024 Mar 15;12(3):660. doi: 10.3390/biomedicines12030660.
6
Molecular Biology and Clinical Management of Esophageal Adenocarcinoma.食管腺癌的分子生物学与临床管理
Cancers (Basel). 2023 Nov 14;15(22):5410. doi: 10.3390/cancers15225410.
7
Genomic signatures of past and present chromosomal instability in Barrett's esophagus and early esophageal adenocarcinoma.巴雷特食管和早期食管腺癌中过去和现在染色体不稳定性的基因组特征。
Nat Commun. 2023 Oct 4;14(1):6203. doi: 10.1038/s41467-023-41805-6.
8
Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma.反流条件通过食管腺癌中的 APE1 氧化还原功能诱导 E-钙黏蛋白裂解和 EMT。
Gut. 2023 Dec 7;73(1):47-62. doi: 10.1136/gutjnl-2023-329455.
9
Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned.反流性食管炎中的食管黏膜抵抗力:我们目前所了解的情况及仍有待了解的内容。
Diagnostics (Basel). 2023 Aug 12;13(16):2664. doi: 10.3390/diagnostics13162664.
10
Identifying Good Candidates for Active Surveillance of Ductal Carcinoma : Insights from a Large Neoadjuvant Endocrine Therapy Cohort.识别导管癌主动监测的合适人选:来自大型新辅助内分泌治疗队列的见解。
Cancer Res Commun. 2022 Dec 7;2(12):1579-1589. doi: 10.1158/2767-9764.CRC-22-0263. eCollection 2022 Dec.
Gut. 2009 Nov;58(11):1451-9. doi: 10.1136/gut.2009.180281. Epub 2009 Aug 2.
4
Routinely diagnosed low-grade dysplasia in Barrett's oesophagus: a population-based study of natural history.巴雷特食管中常规诊断的低度异型增生:一项基于人群的自然史研究。
Histopathology. 2009 Jun;54(7):814-9. doi: 10.1111/j.1365-2559.2009.03316.x.
5
DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus.p16和APC的DNA启动子高甲基化预示着巴雷特食管的肿瘤进展。
Am J Gastroenterol. 2009 Sep;104(9):2153-60. doi: 10.1038/ajg.2009.300. Epub 2009 Jul 7.
6
Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition.欧洲癌症与营养前瞻性调查中的人体测量学与食管癌风险
Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2079-89. doi: 10.1158/1055-9965.EPI-09-0265. Epub 2009 Jun 30.
7
Medication usage and the risk of neoplasia in patients with Barrett's esophagus.药物使用与巴雷特食管患者肿瘤风险。
Clin Gastroenterol Hepatol. 2009 Dec;7(12):1299-304. doi: 10.1016/j.cgh.2009.06.001. Epub 2009 Jun 10.
8
Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends.既往诊断、内镜检查情况及食管腺癌的转归:一项基于人群的时间趋势研究
Am J Gastroenterol. 2009 Jun;104(6):1356-62. doi: 10.1038/ajg.2009.159. Epub 2009 May 12.
9
Radiofrequency ablation in Barrett's esophagus with dysplasia.巴雷特食管伴发育异常的射频消融术。
N Engl J Med. 2009 May 28;360(22):2277-88. doi: 10.1056/NEJMoa0808145.
10
Barrett's dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry.巴雷特异型增生与维也纳分类:可重复性、进展预测以及共识报告和p53免疫组化的影响
Histopathology. 2009 May;54(6):699-712. doi: 10.1111/j.1365-2559.2009.03288.x.